CoChat

Microfluidic-based human prostate-cancer-on-chip

Open access
Jiang, Linan, Khawaja, Hunain, Tahsin, Shekha, Clarkson, Tanjia A., Miranti, Cindy K., Zohar, Yitshak · 2024 · Frontiers in Bioengineering and Biotechnology

The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.

Abstract

Lack of adequate models significantly hinders advances in prostate cancer treatment, where resistance to androgen-deprivation therapies and bone metastasis remain as major challenges. Current in vitro models fail to faithfully mimic the complex prostate physiology. In vivo animal models can shed light on the oncogenes involved in prostate cancer development and progression; however, the animal prostate gland is fundamentally different from that of human, and the underlying genetic mechanisms are different. To address this problem, we developed the first in vitro microfluidic human Prostate-Cancer-on-Chip (PCoC) model, where human prostate cancer and stromal fibroblast cells were co-cultivated in two channels separated by a porous membrane under culture medium flow. The established microenvironment enables soluble signaling factors secreted by each culture to locally diffuse through the membrane pores affecting the neighboring culture. We particularly explored the conversion of the stromal fibroblasts into cancer-associated fibroblasts (CAFs) due to the interaction between the 2 cell types. Immunofluorescence microscopy revealed that tumor cells induced CAF biomarkers, αSMA and COL1A1, in stromal fibroblasts. The stromal CAF conversion level was observed to increase along the flow direction in response to diffusion agents, consistent with simulations of solute concentration gradients. The tumor cells also downregulated androgen receptor (AR) expression in stromal fibroblasts, while an adequate level of stromal AR expression is maintained in normal prostate homeostasis. We further investigated tumor invasion into the stroma, an early step in the metastatic cascade, in devices featuring a serpentine channel with orthogonal channel segments overlaying a straight channel and separated by an 8 µm-pore membrane. Both tumor cells and stromal CAFs were observed to cross over into their neighboring channel, and the stroma’s role seemed to be proactive in promoting cell invasion. As control, normal epithelial cells neither induced CAF conversion nor promoted cell invasion. In summary, the developed PCoC model allows spatiotemporal analysis of the tumor-stroma dynamic interactions, due to bi-directional signaling and physical contact, recapitulating tissue-level multicellular responses associated with prostate cancer in vivo . Hence, it can serve as an in vitro model to dissect mechanisms in human prostate cancer development and seek advanced therapeutic strategies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fbioe.2024.1302223

Cites

102 of 102 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIGURE 1 Prostate-Cancer-on-Chip conceptual model: Cancer and stromal fibroblast cells are co-cultured on opposite surfaces of a porous membrane separating the two aligned channels; normal fibroblasts conversion into CAFs by cancer cells is mediated by secreted soluble factors; large pore-size membrane allows reciprocal cell invasion into neighboring channels.
FIGURE 1 Prostate-Cancer-on-Chip conceptual model: Cancer and stromal fibroblast cells are co-cultured on opposite surfaces of a porous membrane separating the two aligned channels; normal fibroblasts conversion into CAFs by cancer cells is mediated by secreted soluble factors; large pore-size membrane allows reciprocal cell invasion into neighboring channels.CC BY · PubMed Central
FIGURE 2 Microfluidic device fabrication: (A, B) Devices with aligned straight-straight channels and straight-serpentine channels, respectively; (C) major fabrication steps; (D, E) pictures of fabricated devices with straight-straight channels and with straight-serpentine channels, respectively. The channels were filled with different color dyes for visualization.
FIGURE 2 Microfluidic device fabrication: (A, B) Devices with aligned straight-straight channels and straight-serpentine channels, respectively; (C) major fabrication steps; (D, E) pictures of fabricated devices with straight-straight channels and with straight-serpentine channels, respectively. The channels were filled with different color dyes for visualization.CC BY · PubMed Central
FIGURE 3 Simulations of the convection-diffusion flow in a microfluidic device: (A) Schematic illustration of 2D physical model used for simulations depicting transport of signaling molecules through porous membrane due to diffusion from the secreting layer to the receiving layer channel; (B) 2D simulation result of streamwise normalized concentration profiles of secreted molecules along both channels under various flowrates, at a distance 40 µm away from membrane, with the corresponding rainbow maps of planar concentration distributions (inset; blue and red colors represent low and high concentrations, respectively). (C) 2D simulation result of cross-stream normalized concentration profiles of secreted molecules, at mid-distance between channel inlet and outlet, under various flowrates; and (D) 3D simulation result of planar concentration rainbow map showing normalized spatial concentration distribution in serpentine channel. All results are for a device with 8 µm-pore membrane, except curves in brown color in (B, C), which are for a device with 0.8um-pore membrane at flow rate of 30 μL/h.
FIGURE 3 Simulations of the convection-diffusion flow in a microfluidic device: (A) Schematic illustration of 2D physical model used for simulations depicting transport of signaling molecules through porous membrane due to diffusion from the secreting layer to the receiving layer channel; (B) 2D simulation result of streamwise normalized concentration profiles of secreted molecules along both channels under various flowrates, at a distance 40 µm away from membrane, with the corresponding rainbow maps of planar concentration distributions (inset; blue and red colors represent low and high concentrations, respectively). (C) 2D simulation result of cross-stream normalized concentration profiles of secreted molecules, at mid-distance between channel inlet and outlet, under various flowrates; and (D) 3D simulation result of planar concentration rainbow map showing normalized spatial concentration distribution in serpentine channel. All results are for a device with 8 µm-pore membrane, except curves in brown color in (B, C), which are for a device with 0.8um-pore membrane at flow rate of 30 μL/h.CC BY · PubMed Central
FIGURE 4 Immunofluorescence microscopic images of cancer cells and stromal fibroblasts co-cultured in 0.8 µm-pore membrane devices: (A1) EMP cells stained for red-HMWCK and green-TMPRSS2, or (A2) red-ITGα6 and green-TMPRSS2, and (A3) C4-2 cells stained for green-TMPRSS2; (B1) BHPrS1 cells co-cultured with C4-2 cells and stained for red-αSMA and green-COLlA1, (B2) BHPrS1 cells co-cultured with primary tumor spheroids and stained for red-αSMA and green-COLlA1, and (B3) BHPrS1 cells co-cultured with C4-2 cells and stained for green-AR; (C1) BHPrS1 cells co-cultured with normal PrECs and stained for green-vimentin and blue-nuclei; (C2) green COL1A1 and red-αSMA, and (C3) green-AR.
FIGURE 4 Immunofluorescence microscopic images of cancer cells and stromal fibroblasts co-cultured in 0.8 µm-pore membrane devices: (A1) EMP cells stained for red-HMWCK and green-TMPRSS2, or (A2) red-ITGα6 and green-TMPRSS2, and (A3) C4-2 cells stained for green-TMPRSS2; (B1) BHPrS1 cells co-cultured with C4-2 cells and stained for red-αSMA and green-COLlA1, (B2) BHPrS1 cells co-cultured with primary tumor spheroids and stained for red-αSMA and green-COLlA1, and (B3) BHPrS1 cells co-cultured with C4-2 cells and stained for green-AR; (C1) BHPrS1 cells co-cultured with normal PrECs and stained for green-vimentin and blue-nuclei; (C2) green COL1A1 and red-αSMA, and (C3) green-AR.CC BY · PubMed Central
FIGURE 5 Immunofluorescence microscopic images of CAFs converted by cancer cells co-cultured in 8 µm-pore membrane devices: BHPrS1 cells in close proximity with cancer GFP-22Rv1 cells stained for (A1) red-αSMA, (A2) red-αSMA and cyan-POSTN, and (A3) cyan-FAP. BHPrS1 cells in close proximity with cancer GFP-C4-2 cells stained for (B1) red-αSMA, (B2) cyan-vimentin; (B3) BHPrS1 cells at a distal location in the serpentine channel far away from C4-2 cancer cells stained for red-αSMA and cyan-vimentin.
FIGURE 5 Immunofluorescence microscopic images of CAFs converted by cancer cells co-cultured in 8 µm-pore membrane devices: BHPrS1 cells in close proximity with cancer GFP-22Rv1 cells stained for (A1) red-αSMA, (A2) red-αSMA and cyan-POSTN, and (A3) cyan-FAP. BHPrS1 cells in close proximity with cancer GFP-C4-2 cells stained for (B1) red-αSMA, (B2) cyan-vimentin; (B3) BHPrS1 cells at a distal location in the serpentine channel far away from C4-2 cancer cells stained for red-αSMA and cyan-vimentin.CC BY · PubMed Central
FIGURE 6 Microscopic images of cancer cell invasion in co-cultures with BHPrS1 fibroblasts: (A1) GFP-22Rv1 cancer cells plated on the membrane in the upper serpentine channel and mCherry-BHPrS1 fibroblasts plated on the membrane in the lower straight channel on Day 1, (A2) 22Rv1 cells detected in the stroma channel and BHPrS1 CAFs in the cancer channel on Day 7, (A3) high-magnification images of invading cancer cells in the stroma channel, and (A4) CAFs in the cancer cell channel on Day 7. GFP-22Rv1 cells plated on the membrane in the lower straight channel and un-labeled BHPrS1 cells plated on the membrane in the upper serpentine channel with invading 22Rv1 cells detected in the stroma channel on Day 7 at (B1) low and (B2) high magnifications. (C1) In control PrEC/BHPrS1 co-cultures, on Day 14, neither (C1) GFP-PrEC cells nor (C2) mCherry-BHPrS1 cells invade neighboring channel. (D1) GFP-C4-2 cells plated on the membrane in the lower straight channel and mCherry-BHPrS1 fibroblasts plated on the membrane in the upper serpentine channel on Day 1, (D2) invasion of C4-2 cells into the stroma channel and (D3) infiltration of BHPrS1 cells into the cancer cell channel on Day 9 at the respective locations indicated by white squares in (D1), and (D4) retained C4-2 cancer cells attached to the fibroblasts in the stroma channel (blue color arrows) with infiltrated BHPrS1 fibroblasts attached to the tumor channel surfaces (magenta color arrow) after washing the channels with medium.
FIGURE 6 Microscopic images of cancer cell invasion in co-cultures with BHPrS1 fibroblasts: (A1) GFP-22Rv1 cancer cells plated on the membrane in the upper serpentine channel and mCherry-BHPrS1 fibroblasts plated on the membrane in the lower straight channel on Day 1, (A2) 22Rv1 cells detected in the stroma channel and BHPrS1 CAFs in the cancer channel on Day 7, (A3) high-magnification images of invading cancer cells in the stroma channel, and (A4) CAFs in the cancer cell channel on Day 7. GFP-22Rv1 cells plated on the membrane in the lower straight channel and un-labeled BHPrS1 cells plated on the membrane in the upper serpentine channel with invading 22Rv1 cells detected in the stroma channel on Day 7 at (B1) low and (B2) high magnifications. (C1) In control PrEC/BHPrS1 co-cultures, on Day 14, neither (C1) GFP-PrEC cells nor (C2) mCherry-BHPrS1 cells invade neighboring channel. (D1) GFP-C4-2 cells plated on the membrane in the lower straight channel and mCherry-BHPrS1 fibroblasts plated on the membrane in the upper serpentine channel on Day 1, (D2) invasion of C4-2 cells into the stroma channel and (D3) infiltration of BHPrS1 cells into the cancer cell channel on Day 9 at the respective locations indicated by white squares in (D1), and (D4) retained C4-2 cancer cells attached to the fibroblasts in the stroma channel (blue color arrows) with infiltrated BHPrS1 fibroblasts attached to the tumor channel surfaces (magenta color arrow) after washing the channels with medium.CC BY · PubMed Central
FIGURE 7 Invasion of cancer cells placed directly on a fibroblast monolayer in the same channel: (A1) Schematic locations of C4-2 cancer cells and BHPrS1 fibroblast cells on Day 1 and Day 12 of co-culture; (A2) Co-culture of GFP-C4-2 cells and un-labeled BHPrS1 cells with direct physical contact in the lower straight channel while the upper serpentine channel was left empty; (A3) BHPrS1 cells in the upper serpentine channel at the distal locations by Day 5; (B1–B3) GFP-C4-2 cells at the distal locations of the upper serpentine channel, spreading on top of the BHPrS1 cell layer by Day 12; (C1) an initial uniform GFP-C4-2 cell monolayer by Day 3; and (C2) GFP-C4-2 cancer cells expanding to the lower surface of the original straight channel by Day 12; (D1) BHPrS1 cells first migrated into the empty serpentine channel, followed by 22Rv1 cells indicated by blue color arrows; (D2) GFP-22Rv1 cells reached distal location of the serpentine channel by Day 7; (D3) BHPrS1 cells stained for green-αSMA.
FIGURE 7 Invasion of cancer cells placed directly on a fibroblast monolayer in the same channel: (A1) Schematic locations of C4-2 cancer cells and BHPrS1 fibroblast cells on Day 1 and Day 12 of co-culture; (A2) Co-culture of GFP-C4-2 cells and un-labeled BHPrS1 cells with direct physical contact in the lower straight channel while the upper serpentine channel was left empty; (A3) BHPrS1 cells in the upper serpentine channel at the distal locations by Day 5; (B1–B3) GFP-C4-2 cells at the distal locations of the upper serpentine channel, spreading on top of the BHPrS1 cell layer by Day 12; (C1) an initial uniform GFP-C4-2 cell monolayer by Day 3; and (C2) GFP-C4-2 cancer cells expanding to the lower surface of the original straight channel by Day 12; (D1) BHPrS1 cells first migrated into the empty serpentine channel, followed by 22Rv1 cells indicated by blue color arrows; (D2) GFP-22Rv1 cells reached distal location of the serpentine channel by Day 7; (D3) BHPrS1 cells stained for green-αSMA.CC BY · PubMed Central
FIGURE 8 Migration patterns and rates of invading cancer cells: Time-sequence images of cancer cells (seeded in the lower straight channel) invading into neighboring stroma channel (seeded in the upper serpentine channel): (A) GFP-C4-2 cells invading into the channel of mCherry-fibroblasts as cell strands and clusters; (B) GFP-22Rv1 cells invading the channel of unlabeled fibroblasts as tight cell group. (C) Cancer cell migration range based on measured time-dependent distance between the cancer cell front in the fibroblast channel and the edge of the original cancer cell channel. ‘22Rv1/BHP’ or ‘C4-2/BHP’ label indicates co-culture of cancer cells 22Rv1 or C4-2 with stromal BHPrS1 fibroblasts on opposite surfaces of the separation membrane, while ‘22Rv1 on BHP’ or ‘C4-2 on BHP’ label indicates that 22Rv1 or C4-2 cancer cells were placed on top of a stromal BHPrS1 fibroblast monolayer in the same channel. Values in distance were represented as average ± SD of 4 replicates.
FIGURE 8 Migration patterns and rates of invading cancer cells: Time-sequence images of cancer cells (seeded in the lower straight channel) invading into neighboring stroma channel (seeded in the upper serpentine channel): (A) GFP-C4-2 cells invading into the channel of mCherry-fibroblasts as cell strands and clusters; (B) GFP-22Rv1 cells invading the channel of unlabeled fibroblasts as tight cell group. (C) Cancer cell migration range based on measured time-dependent distance between the cancer cell front in the fibroblast channel and the edge of the original cancer cell channel. ‘22Rv1/BHP’ or ‘C4-2/BHP’ label indicates co-culture of cancer cells 22Rv1 or C4-2 with stromal BHPrS1 fibroblasts on opposite surfaces of the separation membrane, while ‘22Rv1 on BHP’ or ‘C4-2 on BHP’ label indicates that 22Rv1 or C4-2 cancer cells were placed on top of a stromal BHPrS1 fibroblast monolayer in the same channel. Values in distance were represented as average ± SD of 4 replicates.CC BY · PubMed Central
FIGURE 9 Cytokine production in Prostate Cancer-on-Chip model. Levels of (A, B) TGFβ and (C) PDGF in conditioned medium measured by ELISA. PDGF was below detectable levels (not shown) in the medium collected from straight channels of both experiments. Conditioned medium was collected every 2 days starting at Day 7, from straight and serpentine channels of 8 µm-pore devices. Straight channel contained BHPrS1 cells and tumor cells, while serpentine channel contained invaded stromal fibroblasts and tumor cells. Error bars = SD; n = 4; *<0.05; **<0.001 relative to Day 7 values.
FIGURE 9 Cytokine production in Prostate Cancer-on-Chip model. Levels of (A, B) TGFβ and (C) PDGF in conditioned medium measured by ELISA. PDGF was below detectable levels (not shown) in the medium collected from straight channels of both experiments. Conditioned medium was collected every 2 days starting at Day 7, from straight and serpentine channels of 8 µm-pore devices. Straight channel contained BHPrS1 cells and tumor cells, while serpentine channel contained invaded stromal fibroblasts and tumor cells. Error bars = SD; n = 4; *<0.05; **<0.001 relative to Day 7 values.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 102 references

Research works printed but not linked: 2

  1. Rao, 2014, Evaluation of myofibroblasts by expression of alpha smooth muscle actin: a marker in fibrosis, dysplasia and carcinoma, J. Clin. Diagnostic Res., 8, ZC14, 10.7860/jcdr/2014/7820.4231 · DOI
  2. Rhee, 2001, Permanent phenotypic and genotypic changes of prostate cancer cells cultured in a three-dimensional rotating-wall vessel, Vitro Cell. Dev. Biol. - Animal, 37, 127, 10.1290/1071-2690(2001)037 · doi:10.1290/1071-2690(2001)037

Cited by

See all 28

Metadata

Authors
Jiang, L., Khawaja, H., Tahsin, S., Clarkson, T. A., Miranti, C. K., & Zohar, Y.
Affiliations
University of Arizona (US)
Corresponding author
Jiang, Linan
Venue
Frontiers in Bioengineering and Biotechnology
Published
2024-01-23
Volume
12
Pages
1302223-1302223
ISSN
2296-4185 (ISSN-L)
OpenAlex
W4391144178
Cited by
26
References
102
Citations by year
2026: 9 · 2025: 11 · 2024: 6
FWCI
2.86
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Bioengineering and Biotechnology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • UA Campus Repository (The University of Arizona) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • University of Washington
  • National Cancer Institute (T32CA009213, R01CA254200, U54CA143924)
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Keywords
prostate cancer, tumor-stroma interactions, cancer-associated fibroblasts, stromal fibroblasts, androgen receptor, androgen deprivation therapy resistance, bone metastasis, tumor invasion, in vitro disease model

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Microfluidic-based human prostate-cancer-on-chip. https://app.cochat.ai/papers/10.3389/fbioe.2024.1302223
The paper
Jiang, L., Khawaja, H., Tahsin, S., Clarkson, T. A., Miranti, C. K., & Zohar, Y. (2024). Microfluidic-based human prostate-cancer-on-chip. Frontiers in Bioengineering and Biotechnology. https://doi.org/10.3389/fbioe.2024.1302223

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.